Prevalence of risk factors of coronary heart disease in Turks living in Germany: The Giessen Study

Atherosclerosis

Volumn 144, Issue 1, 1999, Pages 185-198

  Porsch Oezçueruemez, Mustafa ^a   Bilgin, Yasar ^b   Wollny, Michaela ^c   Gediz, Ayla ^c   Arat, Alev ^d   Karatay, Erdogan ^a   Akinci, Ahmet ^a   Sinterhauf, Klaus ^b   Koch, Heinz ^c   Siegfried, Ingeborg ^a   Von Georgi, Richard ^b   Brenner, Gerhard ^a   Kloer, Hans Ulrich ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b Turkish German Health Foundation   (Germany)

^c Zentralinstitut für Die Kassenärztliche Versorgung in der BRD   (Germany)

^d UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Coronary heart disease; Cross sectional study; Emigrants; Epidemiology; Health status; Lipids; Risk factors; Turks

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; FEMALE; GERMANY; HUMAN; HYPERTENSION; IMMIGRANT; ISCHEMIC HEART DISEASE; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANALYSIS OF VARIANCE; COMORBIDITY; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; EMIGRATION AND IMMIGRATION; FEMALE; GERMANY; HEALTH SURVEYS; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; POPULATION SURVEILLANCE; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION; SMOKING; STRESS; SURVIVAL RATE; TURKEY;

EID: 0345712316     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00054-4     Document Type: Article

References (48)

1. Kannel WB, Gordon T. The Framingham Study. An epidemiological investigation of cardiovascular disease. Section 30: Some characteristics related to the incidence of cardiovascular disease and death. US Government Printing Office. Publication 74-599, 1974.
2. Bhatnagar D, Anand IS, Durrington PN, Patel DJ, Wander GS, Mackness MI, Creed F, Tomenson B, Chandrashekhar Y, Winterbotham M, et al. Coronary risk factors in people from the Indian subcontinent living in west London and their siblings in India. Lancet 1995;345:405-9 see comments.
3. Hughes K, Yeo PP, Lun KC, Thai AC, Sothy SP, Wang KW, Cheah JS, Phoon WO, Lim P. Cardiovascular diseases in Chinese, Malays, and Indians in Singapore. II. Differences in risk factor levels. J Epidemiol Community Health 1990;44:29-35.
4. Hughes K, Lun KC, Yeo PP. Cardiovascular diseases in Chinese, Malays, and Indians in Singapore. I. Differences in mortality. J Epidemiol Community Health 1990;44:24-8.
5. Statistical Yearbook of Germany 1994, Statistisches Bundesamt Wiesbaden, 1994.
6. Bilgin Y, Doppl W, Zekorn T, Bretzel RG and Federlin K. Morbidity and mortality from heart disease in Turks living in Germany. 2nd European Workshop on Lipid Metabolism (Abstracts), 6th-7th Nov. 1987;28.
7. Onat A, Senocak MS, Surdum Avci G, Ornek E. Prevalence of coronary heart disease in Turkish adults. Int J Cardiol 1993;39(1):23-31.
8. Mahley RW, Palaoglu KE, Atak Z, Dawson-Pepin J, Langlois AM, Cheung V, Onat H. Turkish Heart Study: lipids, lipoproteins and apolipoproteins. J Lipid Res 1995;36:839-59.
9. Lüttmann S, Von-Eckardstein A, Wei W, Funke H, Köhler E, Mahley RW, Assmann G. Electrophoretic screening for genetic Variation in apolipoprotein CIII: identification of a novel apo CIII variant, Apo CIII(Asp45 → Asn), in a Turkish patient. J Lipid Res 1994;35(8):1431-40.
10. Onat A, Surdum-Avci G, Senocak M, Ornek E, Gozukara Y. Plasma lipids and their interrelationship in Turkish adults. J Epidemiol Community Health 1992;46:470-6.
11. Bolstorff-Bühler S. Verzehrsgewohnheiten türkischer Mitbürger in Berlin (West). Berlin, D83/.FB 13 Nr. 142, Dissertationsarbeit 1983.
12. Bundesausschub der Ärzte und Krankenkassen. Gesundheitsuntersuchungs-Richtlinien: Richtlinien des Bundesausschusses der Ärzte und Krankenkassen über die Gesundheitsuntersuchung zur Früherkennung von Krankheiten. Bundesarbeitsblatt 1989;10.
13. von Karsa L, Lang A, Kerek-Bodden HE and Flatten, G. Monitoring der Gesundheitsuntersuchung gem. 25 SGB V. Auswertung der Berichtvordrucke der Jahre 1992 und 1993. Deskriptiver Bericht und Tabellensammlung. Zentralinstitut für die kassenärztliche Versorgung in der Bundesrepublik Deutschland, Köln, 1995.
14. Bundesausschub der Ärzte und Krankenkassen. Gesundheitsuntersuchungs-Richtlinien: Richtlinien des Bundesausschusses der Ärzte und Krankenkassen über die Gesundheitsuntersuchung zur Früherkennung von Krankheiten. Bundesarbeitsblatt 1989;10.
15. Lopes-Virella MF, Stone P, Ellis S, Colwell JA. Cholesterol determination in high density lipoproteins separated by three different methods. Clin Chem 1977;23(5):882-8.
16. Wieland H, Seidel D. A simple specific method for precipitation of low density lipoproteins. J Lipid Res 1983;24:904-9.
17. Parra HJ, Mezdour H, Ghalim N, Bard JM, Fruchart JC. Differential electroimmunoassay of human LpA-I lipoprotein particles on ready-to-use plates. Clin Chem 1990;36:1431-5 see comments.
18. Fruchart JC, Kora I, Cachera C, Clavey V, Duthilleul P, Moschetto Y. Simultaneous measurement of plasma apolipoprotein A-I and B by electroimmunoassay. Clin Chem 1982;28(l):59-62.
19. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 1994;89:1333-1445.
20. NIH Consensus conference. Triglyceride, high-density lipoprotein, and coronary heart disease. NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease. J Am Med Assoc 1993;269:505-510.
21. Cooper GR. Standardization of apolipoprotein measurements. In: Widham K, Naito HK, editors. Recent Aspects of Diagnosis and Treatment of Lipid Disorders: Impact on Prevention of Atherosclerotic Diseases. New York: Alain R. Liss, 1987:15574.
22. Geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years. The WHO MONICA Project, World Health Stat. Q. 1988;41:115.
23. Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Munster study. Am J Cardiol 1992;70:733-7.
24. Thomas I, Gupta S, Sempos C, Cooper R. Serum lipids of Indian physicians living in the U.S. compared to U.S.-born physicians. Atherosclerosis 1986;61:99-106.
25. Benfante R. Studies of cardiovascular disease and cause-specific mortality trends in Japanese-American men living in Hawaii and risk factor comparisons with other Japanese populations in the Pacific region: a review. Hum Biol 1992;64(6):791-805.
26. Rao GHR, White JG. Coronary heart disease: an overview of risk factors. Ind Heart J 1993;45(3): 143-53.
27. Onat A, Senocak MS. Relative risk of factors for coronary heart disease in population with low cholesterol levels. Int J Cardiol 1994;43:51.
28. Keil U, Kuulasmaa K. WHO MONICA Project: risk factors [published erratum appears in Int J Epidemiol Sep 1990;19(3):following 775]. Int J Epidemiol 1989;18:46-55.
29. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26year follow-up of participants in the Framingham Heart Study. Circulation 1983;67(5):968-77.
30. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J Clin Res Ed 1984;289(6454):1257-61.
31. Garrison RJ, Feinleib M, Castelli WP, McNamara PM. Cigarette smoking as a confounder of the relationship between relative weight and long-term mortality. The Framingham Heart Study. J Am Med Assoc 1983;249(16):2199-203.
32. Bouchard C. Genetics and the metabolic syndrome. Int J Obes Relat Metab Disord 1995;19(Suppl l):52-9.
33. Bilgin Y, Doppl W, Saur S, Zekorn T, Bretzel RG, Gallisch M, Wirsching M, Federlin K. Besonderheiten bei der internistischen und psychosomatischen Betreuung türkischer Patienten mit koronarer Herzerkrankung in der medizinischen Poliklinik. Klin Wochenschr 1988;66:49.
34. Yarnell JW, Baker IA, Sweetnam PM, Bainton D, O'Brien JR, Whitehead PJ, Elwood PC. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemie heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation 1991;83:836 see comments.
35. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WR, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986;2:33 see comments.
36. Gader A, Bahakim H, Awadalla S, Malaika S. Ethnic variations in the haemostatic system: comparison between Arabs, Westerners (Europeans and Americans), Asians and Africans. Blood Coagul Fibrinolysis 1995;6:537.
37. Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med 1995;332:635 see comments.
38. Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men [published erratum appears in Arterioscler Thromb 1994 Aug;14(8):1392].
39. Arterioscler Thromb 1994;14(l):54-9.
40. Ernst E. Fibrinogen: an important risk factor for atherothrombotic diseases. Ann Med 1994;26(l):15-22.
41. Marti B, Rickenbach M, Keil U, Stieber J, Greiser E, Herman B, Heinemann L, Assmann A, Schadlich H, Nussel E, et al. ariation in coronary risk factor levels of men and women between the German-speaking MONICA centres. Rev Epidemiol Sante Publique 1990;38:479-86.
42. Keys A. Seven Countries: Death and Coronary Heart Disease in Ten Years. Cambridge, MA: Havard University Press, 1980.
43. Blackburn H, Chairman, Epidemiological section. Conference on the health effects of blood lipids: Optimal distribution for populations (American Health Foundation, Workshop, April 1979). Prev Med 1979;8:612-678.
44. Knuiman J, Clive E, Burema J. Serum total and high density lipoprotein cholesterol concentrations and body mass index in adult men from 13 countries. Am J Epidemiol 1982;116(4):631420.
45. Assmann G. Lipid metabolism disorders and coronary heart disease. Primary Prevention, Diagnosis and Therapy Guidelines for General Practice, 2nd Edition. MMW Medizin Verlag, Munich, 1993.
46. Heiss G, Johnson NJ, Reiland S, Davis CE and Tyroler HA. The epidemiology of plasma high-density lipoprotein cholesterol levels. The Lipid Research Clinics Program Prevalence Study. Summary, Circulation 1980;62:IV116.
47. Raiser H. Prävalenz von Risikofaktoren der Atherosklerose unter besonderer Berücksichtigung eines differenzierten Fettstoffwechselbefundes in Abhängigkeit von Nationalität und Arbeitsverhältnis: Untersuchung an 6543 männlichen Industriearbeitern der Altersgruppe 40 bis 60. Inaugural-Dissertation, Göttingen 1983.
48. State Institute of Statistics Prime Ministry Republic of Turkey. Statistical Yearbook of Turkey 1994, Ankara, 1995.